Enzyme immunoassays for specific IgG and IgE antibodies to Pichia pastoris components in normal humans

Journal of Clinical Laboratory Analysis

Volumn 11, Issue 4, 1997, Pages 196-201

  Ohtani, Wataru ^a   Kobayashi, Kaoru ^a   Ohmura, Takao ^a  

^a Green Cross Company   (South Korea)

Author keywords

Allergy; Antibody; Mannan; Mouse; Serum; Yeast

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MANNAN;

ALLERGY; ANALYTIC METHOD; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CROSS REACTION; DELAYED HYPERSENSITIVITY; ENDOMYCETALES; ENZYME IMMUNOASSAY; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; MEDIATOR RELEASE; YEAST;

ADULT; ANIMALS; ANTIBODIES, FUNGAL; ANTIBODY SPECIFICITY; ANTIGENS, FUNGAL; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MALE; MANNANS; MICE; PICHIA; REFERENCE VALUES;

PICHIA PASTORIS; SACCHAROMYCETALES;

EID: 0031010432     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2825(1997)11:4<196::AID-JCLA4>3.0.CO;2-7     Document Type: Article

References (38)

1. Ohi H, Miura M, Hiramatsu R, Ohmura T: The positive and negative cis-acting elements for methanol regulation in the Pichia pastoris AOX2 gene. Mol Gen Genet 243:489-499, 1994.
2. Tsujikawa M, Okabayashi K, Morita M, Tanabe T: Secretion of a variant human single-chain urokinase-type plasminogen activator without an N-glycosylation site in the methylotrophic yeast, Pichia pastoris and characterization of the secreted product. Yeast 12:541-553, 1996.
3. Sumi A, Ohtani W, Kobayashi K, Ohmura T, Yokoyama K, Nishida M, Suyama T: Purification and physicochemical properties of recombinant human serum albumin. In Biotechnology of Blood Proteins, Vol 227. C Rivat, JF Stoltz, eds. Colloque INSERM/John Libbey Eurotext, Montrouge, France, 1993, p 293-298.
4. Yokoyama K, Ohmura T: Production of human serum albumin by biotechnology. Jpn J Apheresis 14:19-20, 1995.
5. Ohtani W, Ohmizu A, Sumi A, Ohmura T, Uemura Y, Yokoyama K: Study on recombinant hepatitis B vaccine: Development of ELISA methods for detection of contaminating yeast components in the vaccine and humoral anti-yeast components antibody developed in humans and guinea-pigs. Yakugaku Zasshi 108:339-344, 1988 (in Japanese).
6. Namba M, Hanafusa T, Kono N, Tarui S. The Gl-G Hypoglycemia Study Group: Clinical evaluation of biosynthetic glucagon treatment for recovery from hypoglycemia developed in diabetic patients. Diab Res Clin Prac 19:133-138, 1993.
7. Wiedermann G, Scheiner O, Ambrosch F, Kraft D, Kollaritsch H, Kremsner P, Hauser P, Simoen E, Andre FE, Safary A: Lack of induction of IgE and IgG antibodies to yeast in humans immunized with recombinant hepatitis B vaccines. Int Archs Allergy Appl Immun 85:130-132, 1988.
8. Kumar BV, Medoff G, Kobayashi GS, Sieling WL: Cross-Reacting Human and Rabbit Antibodies to Antigens of Histplasma capsulatum, Candida albicans, and Saccharomyces cerevisiae. Infect Immun 48:806-812, 1985.
9. Faux JA, Agbarakwe AE, Misbah SA, Chapel HM: A comparison of specific IgG antibody levels to the cell wall mannan of Candida albicans in normal individuals and in patients with primary antibody deficiency. J Immunolog Meth 153:167-172, 1992.
10. Suzuki M, Fukazawa Y: Immunochemical characterization of Candida albicans cell wall antigens: Specific determinant of Candida albicans serotype A mannan. Microbiol Immunol 26:387-402, 1982.
11. Nermes M, Savolainen J, Kortekangas-Savolainen O: Nitrocellullose-RAST analysis of allergenic cross-reactivity of Candida albicans and Saccharomyces cerevisiae mannans. Int Arch Allergy Immunol 106:118-123, 1995.
12. Anicetti V: Improvement and experimental validation of protein impurity immunoassays for recombinant DNA products. In Analytical Biotechnology Capillary Electrophoresis and Chromatography, C Horvath, JG Nikelly, eds. American Chemical Society, Washington, DC, 1990, p 127-140.
13. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275, 1951.
14. Hnatowich DJ, Virzi F, Rusckowski M: Investigations of avidin and biotin for imaging applications. J Nucl Med 28:1294-1302, 1987.
15. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685, 1970.
16. Tijssen P: Practice and theory of enzyme immunoassays. In Laboratory Techniques: Biochemistry and Molecular Biology, RH Burdon, PH van Knippenberg, eds. Elsevier Science B.V., Amsterdam, 1985.
17. Shimane M, Motojima H, Fukushima M: Development of assay methods for antirecombinant human erythropoietin antibodies. J Clin Therap Med 6:33-50, 1990 (in Japanese).
18. Tango T: Rinshou Kensa. In Igaku Toukeigaku Handbook. H Miyahara, T Tango, eds. Asakura Shoten, Tokyo, 1995, p 514-540 (in Japanese).
19. Kobayashi H, Shibata N, Suzuki S: Acetolysis of Pichia pastoris IFO 0948 strain mannan containing α-1,2 and β-1,2 linkages using acetolysis medium of low sulfuric acid concentration. Arch Biochem Biophys 245:494-503, 1986.
20. Gorin PAJ, Spencer JFT, Bhattacharjee SS: Structures of yeast mannans containing both α- and β-linked D-mannopyranose units. Canad J Chem 47:1499-1505, 1969.
21. 1H NMR studies on mannans isolated from very flocculent and weakly flocculent cells of Pichia postoris IFP 206. J Gen Microbiol 136:1279-1284, 1990.
22. Suzuki S: Immunochemical study on mannan, the antigenic polysaccharide of pathogenic yeasts in man of genus Candida. Yakugaku Zasshi 115:280-294, 1995 (in Japanese).
23. Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F: Colorimetric method for determination of sugars and related substances. Anal Chem 28:350-356, 1956
24. Brostoff J, Hall T: Hypersensitivity-Type I. In Immunology, IM Roitt, J Brostoff, DK Male, eds. Gower Medical Publishing, London, 1985, p 19.1-19.17.
25. Parker SL, Leznoff A, Sussman G, Tarlo SM, Krondl M: Characteristics of patients with food-related complaints. J Allergy Clin Immunol 86:503-511, 1990.
26. Kortekangas-Savolainen O, Lammintausta K, Kalimo K: Skin prick test reactions to brewer's yeast (Saccharomyces cerevisiae) in adult atopic dermatitis patients. Allergy 48:147-150, 1993.
27. Kortekangas-Savolainen O, Kalimo K, Lammintausta K, Savolainen J: IgE-binding components of baker's yeast (Saccharomyces cerevisiae) recognized by immunoblotting analysis: Simultaneous IgE binding to mannan and 46-48 kD allergens of Saccharomyces cerevisiae and Candida albicans. Clin Exp Allergy 23:179-184, 1993.
28. Kortekangas-Savolainen O, Savolainen J, Lantto R, Kalimo K: Immediate hypersensitivity to bakery, brewery and wine products in yeast-sensitive atopic dermatitis patients. Clin Exp Allergy 24:836-842, 1994.
29. Ito K, Ishiguro A, Kanbe T, Tanaka K, Torii S: Detection of IgE antibody against Candida albicans enolase and its crossreactivity to Saccharomyces cerevisiae enolase. Clin Exp Allergy 25:522-528, 1995.
30. Wide C, Bennich H, Johansson SGO: Diagnosis of allergy by an in vitro test allergen antibodies. Lancet 2:1105-1107, 1967.
31. Adkinson NF: The radioallergosorbent test in 1981 - limitations and refinements. J Allergy Clin Immunol 67:87-89, 1981.
32. Kemeny DM (ed): A practical guide to ELISA. Pergamon Press, Oxford, 1991.
33. Takei Y, Higashira H, Hayashi K: Improvement of an EIA system for basic fibroblast growth factor by use of biotinylated antibody prepared with NHS-LC-biotin. J Clin Lab Anal 9:96-100, 1995.
34. Akasaki M, Jardieu P, Ishizaka: Immunosuppressive effects of glycosylation inhibiting factor on the IgE and IgG antibody response. J Immunol 136:3172-3179, 1986.
35. Kurup VP, Choi H, Murali PS, Coffman RL: IgE and eosinophil regulation in a murine model of allergic aspergillosis. J Leukoc Biol 56:593-598, 1994.
36. Kudo K, Okudaira H, Miyamoto T, Nakagawa T, Horiuchi Y: IgE antibody response to mite antigen in the mouse: Suppression of an established IgE antibody response by chemically modified antigen. J Allergy Clin Immunol 61:1-9, 1978.
37. Uede T, Ishizaka K: IgE-binding factors from mouse T lymphocytes II: Strain differences in the nature of IgE-binding factor. J Immunol 133:359-367, 1984.
38. Layton GT, Stanworth DR, Amos HE. Factors influencing the immunogenicity of the haptenic drug chlorhexidine in mice: II. The role of the carrier and adjuvants in the induction of IgE and IgG antihapten responses. Immunology 59:459-465, 1986.